The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Interpretation of Continuous Glucose Monitoring Data: Glycemic Variability and Quality of Glycemic Control
Abstract
There are a large number of measures of glycemic variability, including standard deviation (SD), percentage coefficient of variation (%CV), interquartile range (IQR), mean amplitude of glucose excursion (MAGE), mean of daily differences (MODD), and continuous overlapping net glycemic action over an n-hour period (CONGA(n)). These are all highly correlated with the overall or "total" SD, SD(T). SD(T) is composed of several components corresponding to within-day variability, between-day variability (between daily means and between days-within specified time points), and the interaction of these sources of variability. We identify several subtypes of SD; each is highly correlated with SD(T). Variability may also depend on time of day. Numerous measures of quality of glycemic control have been proposed, including a weighted average of glucose values (M)(e.g., M(100) is M at 100 mg/dL), a measure of quality of glycemic control based on mean and SD (J), the Glycemic Risk Assessment Diabetes Equation (GRADE), the Index of Glycemic Control (IGC), the High Blood Glucose Index (HBGI), the Low Blood Glucose Index (LBGI), the Average Daily Risk Range (ADRR), and percentage of glucose values within specified ranges. These methods usually but not always give consistent results: they can differ widely in terms of their ability to detect responses to therapeutic interventions. Based on review of the advantages and limitations of these measures and on extensive experience in the application of these methods, we outline a systematic approach to the interpretation of continuous glucose monitoring data for use by clinical researchers and clinicians to evaluate the quality of glycemic control, glucose variability including within- and between-day variability, the day-to-day stability of glycemic patterns, and changes in response to therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Translating the A1C assay into estimated average glucose values
Nathan, D. M., Kuenen, J., Borg, R., Zheng, H., Schoenfeld, D., Heine, R. J., & for the A1c-Derived Average Glucose (ADAG) Study Group (2008) · Diabetes Care · doi:10.2337/dc08-0545 · Cited by 1,812
Ceriello, A., Esposito, K., Piconi, L., Ihnat, M. A., Thorpe, J. E., Testa, R., Boemi, M., & Giugliano, D. (2008) · Diabetes · doi:10.2337/db08-0063 · Cited by 1,310
Mean Amplitude of Glycemic Excursions, a Measure of Diabetic Instability
Service, F. J., Molnar, G. D., Rosevear, J. W., Ackerman, E., Gatewood, L. C., & Taylor, W. F. (1970) · Diabetes · doi:10.2337/diab.19.9.644 · Cited by 1,039
Improvement in Glycemic Excursions With a Transcutaneous, Real-Time Continuous Glucose Sensor
Garg, S., Zisser, H., Schwartz, S., Bailey, T., Kaplan, R., Ellis, S., & Jovanovic, L. (2006) · Diabetes Care · doi:10.2337/diacare.29.01.06.dc05-1686 · Cited by 433
The M‐Value, an Index of Blood‐sugar Control in Diabetics
SCHLICHTKRULL, J., MUNCK, O., & JERSILD, M. (1965) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1965.tb01810.x · Cited by 385
The Effect of Glucose Variability on the Risk of Microvascular Complications in Type 1 Diabetes
Kilpatrick, E. S., Rigby, A. S., & Atkin, S. L. (2006) · Diabetes Care · doi:10.2337/dc06-0293 · Cited by 377
A Novel Approach to Continuous Glucose Analysis Utilizing Glycemic Variation
McDonnell, C. M., Donath, S. M., Vidmar, S. I., Werther, G. A., & Cameron, F. J. (2005) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2005.7.253 · Cited by 358
Ryan, E. A., Shandro, T., Green, K., Paty, B. W., Senior, P. A., Bigam, D., Shapiro, A. M. J., & Vantyghem, M.-C. (2004) · Diabetes · doi:10.2337/diabetes.53.4.955 · Cited by 343
Evaluation of a New Measure of Blood Glucose Variability in Diabetes
Kovatchev, B. P., Otto, E., Cox, D., Gonder-Frederick, L., & Clarke, W. (2006) · Diabetes Care · doi:10.2337/dc06-1085 · Cited by 333
Kovatchev, B. P., Cox, D. J., Gonder-Frederick, L. A., Young-Hyman, D., Schlundt, D., & Clarke, W. (1998) · Diabetes Care · doi:10.2337/diacare.21.11.1870 · Cited by 310
Symmetrization of the Blood Glucose Measurement Scale and Its Applications
Kovatchev, B. P., Cox, D. J., Gonder-Frederick, L. A., & Clarke, W. (1997) · Diabetes Care · doi:10.2337/diacare.20.11.1655 · Cited by 257
Mazze, R. S., Strock, E., Wesley, D., Borgman, S., Morgan, B., Bergenstal, R., & Cuddihy, R. (2008) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2007.0293 · Cited by 182
Bailey, T. S., Zisser, H. C., & Garg, S. K. (2007) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2007.0205 · Cited by 159
“J”-Index. A New Proposition of the Assessment of Current Glucose Control in Diabetic Patients
Wójcicki, J. (1995) · Hormone and Metabolic Research · doi:10.1055/s-2007-979906 · Cited by 159
Relationship of Fasting and Hourly Blood Glucose Levels to HbA1c Values
Garg, S. K., & Jovanovič, L. (2006) · Diabetes Care · doi:10.2337/dc06-1361 · Cited by 147
Ambulatory Glucose Profile: Representation of Verified Self-Monitored Blood Glucose Data
Mazze, R. S., Lucido, D., Langer, O., Hartmann, K., & Rodbard, D. (1987) · Diabetes Care · doi:10.2337/diacare.10.1.111 · Cited by 144
Self-citationMeasurements of Glucose Control
Service, F. J., O’Brien, P. C., & Rizza, R. A. (1987) · Diabetes Care · doi:10.2337/diacare.10.2.225 · Cited by 140
A method for assessing quality of control from glucose profiles
Hill, N. R., Hindmarsh, P. C., Stevens, R., STRATTON, I. M., Lévy, J., & Matthews, D. R. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02119.x · Cited by 134
Characteristics of Glycemic Stability
Service, F. J., & NELSON, R. L. (1980) · Diabetes Care · doi:10.2337/diacare.3.1.58 · Cited by 116
Rodbard, D. (2007) · Journal of Diabetes Science and Technology · doi:10.1177/193229680700100111 · Cited by 75
Self-citationPernick, N. L., & Rodbard, D. (1986) · Diabetes Care · doi:10.2337/diacare.9.1.61 · Cited by 65
Self-citationPaty, B. W., Senior, P. A., Lakey, J. R. T., Shapiro, A. M. J., & Ryan, E. A. (2006) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2006.8.165 · Cited by 58
The Effect of Glucose Variability on the Risk of Microvascular Complications in Type 1 Diabetes
Hirsch, I. B., & Brownlee, M. (2006) · Diabetes Care · doi:10.2337/dc06-1610 · Cited by 40
Wójcicki, J. (1995) · Hormone and Metabolic Research · doi:10.1055/s-2007-979895 · Cited by 33
Cited by
International consensus on use of continuous glucose monitoring
Danne, T., Nimri, R., Battelino, T., Bergenstal, R. M., Close, K. L., DeVries, J. H., Garg, S., Heinemann, L., Hirsch, I., Amiel, S. A., et al. (2017) · Diabetes Care · doi:10.2337/dc17-1600 · Cited by 2,069
Glycaemic variability in diabetes: clinical and therapeutic implications
Ceriello, A., Monnier, L., & Owens, D. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30136-0 · Cited by 588
van Beers, C. A. J., DeVries, J. H., Kleijer, S. J., Smits, M. M., Geelhoed-Duijvestijn, P. H., Kramer, M. H. H., Diamant, M., Snoek, F. J., & Serné, E. H. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30193-0 · Cited by 386
Closed-loop insulin delivery from bench to clinical practice
Hovorka, R. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.32 · Cited by 342
Bergenstal, R. M., Ahmann, A. J., Bailey, T., Beck, R. W., Bissen, J., Buckingham, B., Deeb, L., Dolin, R. H., Garg, S. K., Goland, R., et al. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0051 · Cited by 307
Metadata
- Authors
- Rodbard, D.
- Venue
- Diabetes Technology & Therapeutics
- Publisher
- SAGE Publications
- Published
- 2009-06-02
- Volume
- 11
- Issue
- S1
- Pages
- S-55-S-67
- ISSN
- 1520-9156 (ISSN-L)
- 1557-8593
- OpenAlex
- W2046262211
- Cited by
- 310
- References
- 24
- FWCI
- 11.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.